CAD associated_with mood disorders
Evidence from:
primary |
all sources
Evidence (5 sources)
Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks.
(2016)
PMID:27028160
primary
The evidence for pleiotropy between CAD and MDD was attenuated substantially (P = .60)
confidence: 0.85
Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks.
(2016)
PMID:27028160
primary
evidence for pleiotropy between CAD and MDD was attenuated substantially (P = .60)
confidence: 0.90
Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks.
(2016)
PMID:27028160
primary
The correlation between CAD and MDD has received much less attention; we found some evidence for genetic correlation between the risks for CAD and MDD.
confidence: 0.90
Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks.
(2016)
PMID:27028160
primary
European American population yielded significant evidence of CAD-MDD pleiotropy (P = 2.39 × 10−5)
confidence: 0.95
Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks.
(2016)
PMID:27028160
primary
novel evidence of genetic overlap between CAD and MDD
confidence: 0.90